Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma (Q37595296)
Jump to navigation
Jump to search
scientific article published on June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma |
scientific article published on June 2010 |
Statements
1 reference
Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma (English)
1 reference
David B T La Vine
1 reference
Teresa A Coleman
1 reference
Carol H Davis
1 reference
Christine E Carbonell
1 reference
Wendy B Davis
1 reference
1 reference
Identifiers
1 reference